Does DARBEPOETIN ALFA Cause Hospitalisation? 5,682 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5,682 reports of Hospitalisation have been filed in association with DARBEPOETIN ALFA (ARANESP). This represents 17.3% of all adverse event reports for DARBEPOETIN ALFA.
5,682
Reports of Hospitalisation with DARBEPOETIN ALFA
17.3%
of all DARBEPOETIN ALFA reports
1,161
Deaths
5,657
Hospitalizations
How Dangerous Is Hospitalisation From DARBEPOETIN ALFA?
Of the 5,682 reports, 1,161 (20.4%) resulted in death, 5,657 (99.6%) required hospitalization, and 9 (0.2%) were considered life-threatening.
Is Hospitalisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DARBEPOETIN ALFA. However, 5,682 reports have been filed with the FAERS database.
What Other Side Effects Does DARBEPOETIN ALFA Cause?
Death (12,264)
Product storage error (1,619)
Off label use (1,586)
Circumstance or information capable of leading to medication error (1,050)
Haemodialysis (907)
Pneumonia (733)
Fall (726)
Anaemia (562)
Dialysis (555)
Haemoglobin decreased (546)
What Other Drugs Cause Hospitalisation?
CLOZAPINE (12,144)
CINACALCET (6,997)
MACITENTAN (3,414)
APIXABAN (3,315)
ADALIMUMAB (3,033)
DUPILUMAB (2,529)
LENALIDOMIDE (2,241)
DENOSUMAB (2,076)
PALIPERIDONE (2,066)
RIOCIGUAT (1,864)
Which DARBEPOETIN ALFA Alternatives Have Lower Hospitalisation Risk?
DARBEPOETIN ALFA vs DARIDOREXANT
DARBEPOETIN ALFA vs DARIFENACIN HYDROBROMIDE
DARBEPOETIN ALFA vs DAROLUTAMIDE
DARBEPOETIN ALFA vs DARUNAVIR
DARBEPOETIN ALFA vs DARUNAVIR ETHANOLATE